1. Home
  2. SLNO vs SEMR Comparison

SLNO vs SEMR Comparison

Compare SLNO & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SEMR
  • Stock Information
  • Founded
  • SLNO 1999
  • SEMR 2008
  • Country
  • SLNO United States
  • SEMR United States
  • Employees
  • SLNO N/A
  • SEMR N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SEMR EDP Services
  • Sector
  • SLNO Health Care
  • SEMR Technology
  • Exchange
  • SLNO Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • SLNO 1.9B
  • SEMR 1.7B
  • IPO Year
  • SLNO 2014
  • SEMR 2021
  • Fundamental
  • Price
  • SLNO $49.17
  • SEMR $16.45
  • Analyst Decision
  • SLNO Strong Buy
  • SEMR Buy
  • Analyst Count
  • SLNO 6
  • SEMR 8
  • Target Price
  • SLNO $74.83
  • SEMR $17.13
  • AVG Volume (30 Days)
  • SLNO 567.7K
  • SEMR 506.5K
  • Earning Date
  • SLNO 03-05-2025
  • SEMR 03-03-2025
  • Dividend Yield
  • SLNO N/A
  • SEMR N/A
  • EPS Growth
  • SLNO N/A
  • SEMR N/A
  • EPS
  • SLNO N/A
  • SEMR 0.08
  • Revenue
  • SLNO N/A
  • SEMR $357,567,000.00
  • Revenue This Year
  • SLNO N/A
  • SEMR $24.50
  • Revenue Next Year
  • SLNO N/A
  • SEMR $20.36
  • P/E Ratio
  • SLNO N/A
  • SEMR $213.76
  • Revenue Growth
  • SLNO N/A
  • SEMR 22.01
  • 52 Week Low
  • SLNO $36.61
  • SEMR $9.64
  • 52 Week High
  • SLNO $60.92
  • SEMR $16.52
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 56.57
  • SEMR 79.11
  • Support Level
  • SLNO $45.44
  • SEMR $11.45
  • Resistance Level
  • SLNO $49.03
  • SEMR $12.10
  • Average True Range (ATR)
  • SLNO 2.36
  • SEMR 0.56
  • MACD
  • SLNO 0.66
  • SEMR 0.55
  • Stochastic Oscillator
  • SLNO 98.40
  • SEMR 97.12

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: